Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

8.79
Delayed Data
As of 4:00pm ET
 +0.295 / +3.47%
Today’s Change
2.48
Today|||52-Week Range
9.25
+38.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash21.3M54.7M30.5M23.7M
 
 
 
 
 
Short Term Investment Cash273.0K33.4M-25.6M-6.9M
 
 
 
 
 
Cash & Short Term Investments38.2M72.9M53.2M56.2M
 
 
 
 
 
 
ReceivablesReceivables2.1M9.5M6.2M8.8M
 
 
 
 
 
 
InventoriesInventories0.00683.0K1.6M500.0K
 
 
 
 
 
Current AssetsOther Current Assets1.7M6.2M4.9M1.4M
 
 
 
 
 
Current Assets42.0M89.3M65.9M66.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross14.4M14.2M19.4M14.8M
 
 
 
 
 
Depreciation-14.1M-14.0M-14.2M-4.9M
 
 
 
 
 
Other Assets3.9M6.3M5.8M4.1M
 
 
 
 
 
Total Assets48.9M136.9M124.6M89.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.2M2.8M9.3M4.3M
 
 
 
 
 
Short Term Debt0.0030.0M30.0M28.2M
 
 
 
 
Accrued Expenses5.7M9.5M15.7M10.4M
 
 
 
 
 
Other Current Liabilities11.1M22.7M24.7M21.4M
 
 
 
 
 
Other Liabilities15.3M57.7M64.5M54.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt30.0M0.002.4M25.5M
 
 
 
 
Other Liabilities0.000.00329.0K244.0K
 
 
 
Total Liabilities50.0M61.2M76.8M88.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-1.1M75.6M47.7M1.6M
 
 
 
 
 
Total Shareholder Equity-1.1M75.6M47.7M1.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding59.1M72.0M73.4M73.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.